Home dialysis device gets safety check in ongoing study
NCT ID NCT04198012
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study allowed 25 people with end-stage kidney disease to keep using the HemoCare hemodialysis system at home while the device was being reviewed for market approval. The main goal was to track safety events like side effects or device problems. Participants needed a trained care partner to help with treatments.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
HemoCare™ Hemodialysis System (a device for home hemodialysis)
What this could lead to
If successful, this could help make home hemodialysis more accessible for people with kidney failure, offering more flexibility and convenience.
What could go wrong
This is a small, completed study focused on continued access and safety monitoring, not a test of new benefits. The device still requires a trained care partner and may not suit everyone.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for END STAGE RENAL DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
DCI North Brunswick
North Brunswick, New Jersey, 08902, United States
-
Dialysis Clinic, Inc.
Knoxville, Tennessee, 37920, United States
-
Dialysis Clinic, Inc.
Nashville, Tennessee, 37203, United States
-
The Rogosin Institute
New York, New York, 11021, United States
-
University of Mississippi Medical Center
Jackson, Mississippi, 39213, United States
-
Wellbound North Austin
Austin, Texas, 78758, United States
-
Wellbound South Austin
Austin, Texas, 78744, United States